Press Releases

Date Title and Summary View
Toggle Summary Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections
Millipore and Oxford Immunotec Co-develop Plates for Diagnosing and Monitoring Infections Billererica, MA, USA and Oxford, UK, 21 September 2005 - Millipore Corporation (NYSE:MIL) and Oxford Immunotec Ltd. announced today the co-development of a specially designed microtitre plate for use in
View HTML
Toggle Summary Oxford Immunotec Closes £7M in Series B Financing
Oxford Immunotec Closes £7M in Series B Financing Oxford, UK; 3 August 2005 - Oxford Immunotec, the T cell diagnostics company, announced today that it has closed a £7M series B private equity financing. The round was led by Prelude Ventures, who invested £2.75M, alongside Quester,
View HTML
Toggle Summary Oxford Immunotec Prevails in Core Patent Dispute with Cellestis and Sanofi-Pasteur
Oxford Immunotec Prevails in Core Patent Dispute with Cellestis and Sanofi-Pasteur Oxford, UK; 11 July 2005 - Oxford Immunotec, the T-cell diagnostics company, announced today that its core patent, number 0941478, has been upheld by the European Patent Office (EPO).
View HTML